Haemophilus B conjugate vaccine (meningococcal protein conjugate, Merck Sharp & Dohme)

bๅž‹ๆตๆ„Ÿๅ—œ่ก€ๆ†่Œ็ป“ๅˆ็–ซ่‹—๏ผˆ้ป˜ๆฒ™ไธœ๏ผ‰

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHaemophilus B conjugate vaccine (meningococcal protein conjugate, Merck Sharp & Dohme)
Drug Alias NameBๅž‹ๅ—œ่ก€ๆ†่Œ็ป“ๅˆ็–ซ่‹—๏ผˆ่„‘่†œ็‚Ž็ƒ่Œ่›‹็™ฝๅถ่”๏ผŒ้ป˜ๆฒ™ไธœ๏ผ‰Liquid PedvaxHIBPedvaxHIBๆ™ฎๆณฝๆฌฃ
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Conjugated vaccine +[4]ย 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHaemophilus Infections
Global Approved IndicationsHaemophilus Infections
Approved Indications in ChinaHaemophilus Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1989/12/20
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme Corp
Inactive CompaniesN/A
Active IndicationsHaemophilus Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ07AG01
Related LinksN/A